by plexusventures_h3tnl0 | Aug 17, 2017 | Uncategorized
Philadelphia, PA – Plexus Ventures, a global pharmaceutical consulting firm, announces its collaboration with Celon Pharma SA, Łomianki, Poland. Michael O’Sullivan Managing Partner London Office, noted: “We are very pleased to provide continuing support to an...
by plexusventures_h3tnl0 | Jun 13, 2017 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce it assisted the successful completion of a transaction in which Vendis Capital, a European private equity fund specialized in the consumer brands sector, invested in Sylphar, a fast-growing,...
by plexusventures_h3tnl0 | May 22, 2017 | Uncategorized
Philadelphia, PA – Plexus Ventures is pleased to announce that its client, Fujifilm Kyowa Kirin Biologics (FKB), has confirmed that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application for FKB327 (adalimumab biosimilar)....
by plexusventures_h3tnl0 | Jan 19, 2017 | Uncategorized
Tokyo, Japan – Plexus Ventures is pleased to announce the successful completion of an out-licensing project on behalf of Cynata Therapeutics Ltd. Plexus provided professional services to Cynata in the out-licensing of its lead product, CYP-001, to FUJIFILM...
Recent Comments